FREE CASE EVALUATION: +1-888-885-2771                                          Email us:


Bayer Looks to Replace Roundup Weed Killer as Lawsuits Continue to Mount


As lawsuits involving cancer in the fight against Roundup, the weedkiller, continue to draw attention, Bayer – which became Roundup’s owner after it purchased Monsanto in the year prior has made plans to invest over $5.6 billion in the next ten years to create new strategies to fight the weeds.

Bayer’s announcement comes as the company tries to meet the competing deadlines for appeals in three necessary Roundup trials. Decisions in each of these cases have been against Bayer. They include the case of a California jury that recently handed out a couple of billion dollars after finding that exposure to Roundup caused the diagnosis of cancer in them.

Before it was sold to Germany-based Bayer, Monsanto was headquartered in St. Louis, Missouri and is now in the midst of a new round of trials. Sharlean Gordon, a woman in her 50s, claims that Roundup has caused cancer in her body and will be going to court in March. The judge who presided had recently denied Monsanto’s request for summary judgment before trial and also rejected the company’s request not to include the opinions of a variety of experts. The case was filed in July of 2017 for the plaintiffs, which is more than 75 is the first case of this group to go to trial.


At present, more than 13,400 plaintiffs, including several customers from The Justice Now, have brought lawsuits to Bayer across the U.S. In each of these lawsuits, the plaintiffs have contracted non-Hodgkin’s lymphoma, or a different type of cancer as a result of the exposure of Roundup, or other weed killers that contain Glyphosate.

Glyphosate has been identified as cancer-causing by The World Health Organization’s International Agency for Research on Cancer and California’s Office of Environmental Health Hazard Assessment. It has been sprayed more frequently than any other chemical used in agriculture in the past.

This has caused businesses like Costco to discontinue selling Roundup, and the pressure is increasing on retailers like Home Depot and Lowe’s to stop carrying the weed killer that has been criticized for its controversial nature.

Environmentalists, in turn, are becoming more active. Alongside their assertions against Roundup, environmental groups are concerned about tiny amounts of the same cancer-causing chemical, Glyphosate, in snacks and cereal like Cheerios.


With the stock price of Bayer falling 44 per cent in August 2018, in addition to Bayer investors becoming increasingly agitated, Many believe that Bayer will try to reach a global agreement over Roundup litigation. Roundup lawsuits. The estimates of experts suggest that the settlements could reach as high as $10 billion.

This is the perfect moment to act now if you or someone close to you have cancer due to using Roundup or another glyphosate-based herbicide. Contact our Roundup  expert by calling 573-464-6698 or click here for information about your rights as a legal person. Make sure you hold Bayer accountable.

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Your Free

Case Evaluation!

The fee is free, you only pay when you win!

Recent News


Sharing is caring.. ?


Get Your compensation now, before it gets too late

The fee is free, you only pay when you win. Get Free Consultation from our expert lawyers.

The Justice Now Legal News

The biggest loser — workers’ compensation?

When you see a person you’ve not seen for several months, You’re probably to ask: “Gee, you look great. Have you lost weight?” The most likely answer is Ozempic Wegovy and Mounjaro. Ozempic, as well as Mounjaro, were designed for treating Type 2 diabetes; Wegovy explicitly intended to be a weight-loss drug, making use of the same semaglutide formulation used in Ozempic.

The Justice Now Legal News

Doctor asks court to toss J&J lawsuit against her over cancer research

A medical scientist has asked the court to dismiss the lawsuit Johnson & Johnson brought against her for her 2019 research on the link between cosmetic talc and cancer. She argued that her work is reliable and is protected by the freedom of speech rights.

The Justice Now Legal News

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court?

Appeals court OKs ‘common benefit’ fees in Bard IVC filter litigation. Next stop the Supreme Court? – Lawyers representing plaintiffs who have signed agreements to pay a portion of their fee to chiefs of significant multidistrict litigation have to respect those agreements even if they decide to settle disputes outside the process, as per a federal appeals court ruling that week.

The Justice Now Legal News

Navy, Justice Dept. offer payouts in bid to speed up Camp Lejeune claims

The United States Department of Justice and U.S. Navy announced a program of tier-based payouts to those whom the water contamination on Marine Corps Base Camp Lejeune has harmed.

Ozempic Lawsuit

Ozempic Lawsuit: What you need to know

Ozempic Lawsuit: What you need to know – Ozempic (semaglutide) is an injection of 0.5- 2 mg, an injectable prescribed medicine used by type 2 – diabetic patients to lower the risk of heart attack, stroke, or death. Also, some of them are used for weight loss.

Bard PowerPort Catheter Lawsuit

All You Need to Know About Bard PowerPort Catheter Lawsuit: Latest Updates 2023 and Eligibility Criteria

Bard Powerport Catheter Lawsuit Updates 2023

You might also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

Free Consultation?

Fill out your details and we will get back to you as soon as possible.